Update on a New Clinical Trial Offered to Eligible GIST Patients

The INTRIGUE study is a Phase 3 clinical trial testing the investigational drug ripretinib (DCC-2618) for patients living with GIST that are no longer on imatinib due to progression or intolerance.

By |2019-08-21T11:40:48-04:00June 20th, 2019|Clinical Trials, News, Newsletter|

One Voice Against Cancer (OVAC) Advocates for Cancer Patients

OVAC is a coalition of over 50 nonprofit cancer organizations that advocate on behalf of cancer patients to deliver a unified message to Congress and to the White House on the need for increased [...]

By |2019-07-02T14:28:52-04:00June 20th, 2019|Advocacy, News, Newsletter|

The LRG GIST Peer Support Program

[Please note that GIST Peer Support program has been renamed the GIST Mentor Program 11.5.19]. Last month, we posted information on our new program to support our members. The GIST Peer Program is an additional support system to help patients and their caregivers through a very difficult time in their lives. Why? They may just be finding out they or a loved one has GIST, or they are experiencing a recurrence and they want to be able to talk with someone.

By |2019-11-05T17:10:28-05:00June 20th, 2019|News, Newsletter, Patient Support|

Global Representative Spotlight – Adriana María Garzón Pinzón, Colombia

Adriana’s journey with cancer began 15 years ago. After conquering Stage 3 breast cancer, she changed her professional path and poured her skills, talents, and experience into serving other cancer patients. In 2004, Adriana, [...]

By |2019-07-03T10:10:41-04:00June 20th, 2019|Global, Newsletter, Patient Support|
Go to Top